| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.12 | 0.007 |